By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: DC Conference: FDA At A Crossroads
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > DC Conference: FDA At A Crossroads
BusinessMedical DevicesPolicy & LawTechnology

DC Conference: FDA At A Crossroads

gooznews
gooznews
Share
2 Min Read
SHARE

This one looks interesting. The Union of Concerned Scientists is holding a conference next week (Nov. 15) at George Washington University in Washington, D.C. that will explore many of the pressing issues at the Food and Drug Administration. FDA chief Margaret Hamburg is scheduled to give the keynote address, probably around 8:30 a.m. when the conference kicks off. Here’s the full agenda:

This one looks interesting. The Union of Concerned Scientists is holding a conference next week (Nov. 15) at George Washington University in Washington, D.C. that will explore many of the pressing issues at the Food and Drug Administration. FDA chief Margaret Hamburg is scheduled to give the keynote address, probably around 8:30 a.m. when the conference kicks off. Here’s the full agenda:

9:30 AM
Panel 1: Patient Safety

Moderator: Tom Burton, J.D., The Wall Street Journal
How can the FDA better monitor clinical trials and approved drugs and improve the process for predicting drug and device safety?
11:00 AM
Panel 2: The Efficacy of Drugs and Devices Regulated by the FDA

Moderator: John Powers, M.D., George Washington University School of Medicine
How can evidence-based medicine, meta-analysis, comparative effectiveness, and off-label use policies be improved and effectively implemented?
2:00 PM
Panel 3: Scientific Integrity at the FDA

Moderator: Francesca Grifo, Ph.D., Union of Concerned Scientists
How can the FDA better promote a culture of transparency and scientific integrity, protect the rights of scientists and whistleblowers, and limit political and corporate interference in agency policy decisions?
3:15 PM
Panel 4:  Institutional Challenges at the FDA
Moderator: Susan Wood, Ph.D., George Washington School of Public Health and Health Services
How do conflicts of interest impact the work of agency advisory committees? How can the agency best allocate limited resources? Are current policies regarding user fees effective?

To register, go to this link.

TAGGED:conferencesFDA
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Pfizer Has a New Sales Strategy–Will Be Selling Lipitor at Generic Prices When Patent Runs Out

November 22, 2011

Medical Tourism Initiative Enables Nigerian Hospital to Deliver Quality Medical Care

December 17, 2013

Why Aren’t Health Care Prices Ever on The Table?

September 18, 2012

UVA Summit, 2nd Day – Ozmosis Interview

March 5, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?